Surface Oncology Inc logo

Surface Oncology Inc Share Price (NASDAQ: SURF)

▲

-1.07

(-100%)

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 6 Sep 2023

Check the interactive Surface Oncology Inc Stock chart to analyse performance

Surface Oncology Inc Key Stats

Check Surface Oncology Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.07
Open
$1.06
Market Capitalization
$65.7M
Today's Volume
$1.5M
Revenue TTM
$0.0
EBITDA
$-83.2M
Earnings Per Share (EPS)
$-1.66
Dividend Yield
0.0%
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-105.78%

Global Institutional Holdings in Surface Oncology Inc

  • Name

    Holdings %

  • Armistice Capital, LLC

    8.04%

  • Atlas Venture Associates IX, LLC

    4.84%

  • Vanguard Group Inc

    3.80%

  • ARK Investment Management LLC

    2.32%

  • Dafna Capital Management LLC

    1.81%

  • Acadian Asset Management LLC

    1.73%

Analyst Recommendation on Surface Oncology Inc Stock

Rating
Trend

Buy

    63%Buy

    36%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Surface Oncology Inc(by analysts ranked 0 to 5 stars)

About Surface Oncology Inc

Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 which is in phase II clinical trial targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 that is in phase 1/2 clinical trials targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited and Vaccinex, Inc. to develop, manufacture, and commercialize antibodies, which targets SRF114. The company was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Organization
Surface Oncology Inc
Employees
35
CEO
Dr. Robert W. Ross M.D.
Industry
Health Technology

Important FAQs about investing in SURF Stock from India :

What is Surface Oncology Inc share price today?

Surface Oncology Inc share price today is as on at the close of the market. Surface Oncology Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Surface Oncology Inc share?

Surface Oncology Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Surface Oncology Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Surface Oncology Inc Stock (SURF) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Surface Oncology Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Surface Oncology Inc Shares .

What is the minimum amount required to buy Surface Oncology Inc Stock (SURF) from India?

Indian investors can start investing in Surface Oncology Inc (SURF) shares with as little as ₹93.46 or $1 (as of March 23, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹934.60 in Surface Oncology Inc stock (as per the Rupee-Dollar exchange rate as on March 23, 2026). Learn more about fractional shares .

What are the returns that Surface Oncology Inc has given to Indian investors in the last 5 years?

Surface Oncology Inc stock has given 0.0% share price returns and 29.12% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?